13F

Stock

Keros Therapeutics, Inc.

KROS · held by 1 managers

Reported value

$1.7M

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$2.53M

Price effect on 1 books still in the name

Largest holder

$1.7M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC107.5K$1.7M−$2.53MCut−$1.78M

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.